| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.25B | -20.7% |
| Cost of Revenue | $1.23B | -20.0% |
| R&D Expense | $61.9M | +8.1% |
| SG&A Expense | $145.9M | -20.5% |
| Operating Income | -$443.6M | +20.8% |
| Interest Expense | $41.3M | +449.0% |
| Pre-tax Income | -$486.0M | +12.5% |
| Income Tax | $1.4M | +713.5% |
| Net Income | -$487.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $263.9M | -55.0% |
| Accounts Receivable | $38.2M | -66.0% |
| Inventory | $20.4M | -29.7% |
| Current Assets | $434.0M | -47.0% |
| Total Assets | $1.32B | -31.6% |
| Current Liabilities | $907.5M | -32.5% |
| Long-term Debt | $615.3M | +127.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$665.3M | -188.4% |
| Capital Expenditures | $20.2M | -75.9% |
| Investing Cash Flow | $40.9M | +123.3% |
| Financing Cash Flow | $301.0M | +22.9% |
| Free Cash Flow | -$685.5M | -118.1% |
| +12.2% |
| EPS (Basic) | -$3.69 | -63.3% |
| EPS (Diluted) | -$3.69 | -63.3% |
| Total Liabilities |
| $1.22B |
| -27.2% |
| Stockholders' Equity | $97.4M | -61.3% |